Halyard Health, Inc. (HYH) EPS Estimated At $-0.04

April 17, 2018 - By Margaret Downey

Halyard Health, Inc. (NYSE:HYH) Logo

Analysts expect Halyard Health, Inc. (NYSE:HYH) to report $-0.04 EPS on May, 1.They anticipate $0.52 EPS change or 108.33 % from last quarter’s $0.48 EPS. After having $0.73 EPS previously, Halyard Health, Inc.’s analysts see -105.48 % EPS growth. The stock increased 1.63% or $0.77 during the last trading session, reaching $47.87. About 244,163 shares traded. Halyard Health, Inc. (NYSE:HYH) has risen 20.55% since April 17, 2017 and is uptrending. It has outperformed by 9.00% the S&P500.

Halyard Health, Inc. operates as a medical technology firm that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. The company has market cap of $2.25 billion. The firm operates through two divisions, Medical Devices and Surgical and Infection Prevention . It has a 28.33 P/E ratio. The Medical Devices segment provides a portfolio of products that focuses on pain management, and respiratory and digestive health to enhance patient outcomes.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: